Cyntellect Appoints David Voris Chief Financial Officer
San Diego, CA – November 13, 2007
|
Cyntellect Completes Second Closing of Series D Private Financing
$18.1 million raised; Potential for up to $28.4 million.
San Diego, CA - September 6, 2007
|
Cyntellect Completes $15.1 Million Series D Private Financing
Transaction to drive workforce and facility expansion; could yield up to $23.4MM investment
San Diego, CA - July 25, 2007
|
Cyntellect Awarded $1.3MM Phase II SBIR Grant to Automate Cloning of Cell Based on Protein Secretion
Novel application of LEAP™ to accelerate cell-based R&D and manufacturing efforts.
San Diego, CA - May 9, 2007
|
Cyntellect Appoints Drs. Alan Aderem, Charles Cantor and Michael Hanley to Its Scientific Advisory Board
New members to foster expanded applications of cell-based manipulation from functional proteomics to stem cells.
San Diego, CA - January 24, 2007
|
Cyntellect LEAP™ System Receives CE Marking
First European shipment of LEAP™ goes to major pharmaceutical company customer.
San Diego, CA - September 8, 2006
|
Cyntellect
Awarded $500,000 Phase IIB SBIR Grant Funding to Advance Development of
Laser-based Transfection ("Optoinjection")
Technology Offers New Approach for High-efficiency, Low-toxicity
Delivery of siRNA into Broad Range of Cell Types
San Diego, CA - June 27, 2006
|
Summit
Pharmaceuticals (formally SC Biosciences) Enters Agreement to Distribute
Cyntellect's LEAP™ Technology in Japan
Laser-based technology poised to enhance the quality, speed and
robustness of cell purification, analysis and transfection. Shipping slated
for early 2006.
San Diego, CA and Tokyo, Japan - August 9, 2005
|
Daiichi
Enters Funded Research Agreement With Cyntellect
San Diego, CA - March 30, 2005
|
